These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8624976

  • 1. Serum insulin, IGF-I,IGF-II and growth hormone, and left ventricular mass in noninsulin-dependent mellitus.
    Rabkin SW, Dawson KG, Bhaumick B, O'Brein E, Kendler DL.
    Can J Cardiol; 1996 Mar; 12(3):264-70. PubMed ID: 8624976
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
    Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G, Perticone F.
    J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
    [Abstract] [Full Text] [Related]

  • 3. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M, Uemasu J, Kawasaki H.
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [Abstract] [Full Text] [Related]

  • 4. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 6. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 7. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N.
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 10. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 11. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes.
    Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson JM, Brismar K.
    Am J Med; 2006 Feb; 119(2):167.e9-15. PubMed ID: 16443426
    [Abstract] [Full Text] [Related]

  • 12. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T, Juul A, Juul Holst J, Feldt-Rasmussen U.
    Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
    Roth S, Abernathy MP, Lee WH, Pratt L, Denne S, Golichowski A, Pescovitz OH.
    J Soc Gynecol Investig; 1996 Jun; 3(2):78-84. PubMed ID: 8796812
    [Abstract] [Full Text] [Related]

  • 14. Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects.
    Uusitupa M, Siitonen O, Pyörälä K, Mustonen J, Voutilainen E, Hersio K, Penttilä I.
    Diabetes Res; 1987 Jan; 4(1):19-25. PubMed ID: 3552363
    [Abstract] [Full Text] [Related]

  • 15. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
    Maison P, Balkau B, Souberbielle JC, Cunin P, Vol S, Macquin-Mavier I, Eschwège E, D. E. S. I. R. Study Group.
    Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy.
    Díez J, Laviades C, Martínez E, Gil MJ, Monreal I, Fernández J, Prieto J.
    J Hypertens; 1995 Mar; 13(3):349-55. PubMed ID: 7542683
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure.
    Santos DP, Okoshi K, Moreira VO, Seiva FR, Almeida FL, Padovani CR, Carvalho RF, Okoshi MP, Cicogna AC, Castro AV, Pai-Silva MD.
    Growth Horm IGF Res; 2010 Apr; 20(2):149-55. PubMed ID: 20060348
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-I in patients on CAPD and hemodialysis: relationship to body weight and albumin level.
    Kagan A, Altman Y, Zadik Z, Bar-Khayim Y.
    Adv Perit Dial; 1995 Apr; 11():234-8. PubMed ID: 8534712
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus.
    Kanazawa I, Yamaguchi T, Sugimoto T.
    Growth Horm IGF Res; 2011 Oct; 21(5):268-71. PubMed ID: 21839662
    [Abstract] [Full Text] [Related]

  • 20. Serum insulin-like growth factor-I concentrations in late middle age: no association with birthweight in three UK cohorts.
    Holt RI, Syddall HE, Phillips DI, Martyn CN, Gluckman PD, Breier BH, Wood PJ, Fall CH.
    Acta Physiol Scand; 2004 Apr; 180(4):359-66. PubMed ID: 15030377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.